We are live on
!
Find out more
LP
Lexington Partners Portfolio holdings
AUM
$134M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.78%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$235M
AUM Growth
+$44.2M
(+23%)
Cap. Flow
+$45.1M
Cap. Flow
% of AUM
19.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNB
Dun & Bradstreet
DNB
|
+$51M |
| 2 |
Krispy Kreme
DNUT
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Compass
COMP
|
+$21.4M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$545K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 55.78% |
| 2 | Financials | 23.34% |
| 3 | Technology | 13.33% |
| 4 | Real Estate | 7.54% |
| 5 | Healthcare | 0% |
Similar funds
RA
SWM
SA
SA
GEH
BGI
MMCM
STFP
Lexington Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Lexington Partners held 7 positions worth $235M, up 23% from $191M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lexington Partners deployed $45.1M of net new capital in Q4 2021, opening 2 new positions. Its largest new stake was Dun & Bradstreet: 2,679,211 shares worth $54.9M.
By sector, the portfolio is most concentrated in Consumer Staples at 56% of assets, up from 54% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Compass, an estimated $21.4M trimmed.
- Lexington Partners's largest Q4 2021 buy was Dun & Bradstreet: 2,679,211 shares worth $54.9M.
- Lexington Partners's biggest Q4 2021 reduction was Compass, cutting an estimated $21.4M.
- Lexington Partners fully exited Syndax Pharmaceuticals in Q4 2021, selling an estimated $545K.
- Lexington Partners's ten largest holdings make up 100% of its $235M portfolio in Q4 2021.
- Lexington Partners opened 2 new positions and closed 1 in Q4 2021.
- Lexington Partners's portfolio value rose 23% quarter-over-quarter to $235M.
Based on Lexington Partners's 13F filing for Q4 2021, filed 11 Feb 2022.